Cord factors from atypical mycobacteria (Mycobacterium alvei, Mycobacterium brumae) stimulate the secretion of some pro-inflammatory cytokines of relevance in tuberculosis

Microbiology (United Kingdom)

Volumn 158, Issue 11, 2012, Pages 2878-2885

  Linares, Carlos ^a   Bernabéu, Antonia ^b   Luquin, Marina ^c   Valero Guillén, Pedro L ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CORD FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATYPICAL MYCOBACTERIUM; BACTERIAL CELL; CONTROLLED STUDY; CYTOKINE RELEASE; MYCOBACTERIUM ALVEI; MYCOBACTERIUM BRUMAE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS;

ANIMALS; CELL LINE; CORD FACTORS; CYTOKINES; HUMANS; INFLAMMATION MEDIATORS; MICE; NONTUBERCULOUS MYCOBACTERIA; TUBERCULOSIS; UP-REGULATION;

ATYPICAL MYCOBACTERIUM; MYCOBACTERIUM ALVEI; MYCOBACTERIUM BRUMAE; MYCOBACTERIUM TUBERCULOSIS;

EID: 84868319856     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.060681-0     Document Type: Article

References (45)

1. Ausina, V., Luquin, M., García Barceló, M., Lanéelle, M. A., Lévy-Frébault, V., Belda, F. & Prats, G. (1992). Mycobacterium alvei sp. nov. Int J Syst Bacteriol 42, 529-535.
2. Beckman, E. M., Porcelli, S. A., Morita, C. T., Behar, S. M., Furlong, S. T. & Brenner, M. B. (1994). Recognition of a lipid antigen by CD1-restricted a b+ T cells. Nature 372, 691-694.
3. Bloch, H. (1950). Studies on the virulence of tubercle bacilli; isolation and biological properties of a constituent of virulent organisms. J Exp Med 91, 197-218.
4. Bowdish, D. M. E., Sakamoto, K., Kim, M.-J., Kroos, M., Mukhopadhyay, S., Leifer, C. A., Tryggvason, K., Gordon, S. & Russell, D. G. (2009). MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis. PLoS Pathog 5, e1000474.
5. Brennan, P. J. & Nikaido, H. (1995). The envelope of mycobacteria. Annu Rev Biochem 64, 29-63.
6. Cooper, A. M. & Khader, S. A. (2008). The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol Rev 226, 191-204.
7. Cruz, A., Fraga, A. G., Fountain, J. J., Rangel-Moreno, J., Torrado, E., Saraiva, M., Pereira, D. R., Randall, T. D., Pedrosa, J. & other authors (2010). Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis. J Exp Med 207, 1609-1616.
8. Daffé, M. & Draper, P. (1997). The envelope layers of mycobacteria with reference to their pathogenicity. Adv Microb Physiol 39, 131-203.
9. Dao, D. N., Sweeney, K., Hsu, T., Gurcha, S. S., Nascimento, I. P., Roshevsky, D., Besra, G. S., Chan, J., Porcelli, S. A. & Jacobs, W. R., Jr (2008). Mycolic acid modification by the mmaA4 gene of M. tuberculosis modulates IL-12 production. PLoS Pathog 4, e1000081.
10. Dobson, G., Minnikin, D. E., Minnikin, S. M., Parlett, J. H., Goodfellow, M., Ridell, M. & Magnusson, M. (1985). Systematic analysis of complex mycobacterial lipids. In Chemical Methods in Bacterial Systematics, pp. 237-265. Edited byM. Goodfellow & D. E. Minnikin. London: Academic Press.
11. Eckstein, T. M., Chandrasekaran, S., Mahapatra, S., McNeil, M. R., Chatterjee, D., Rithner, C. D., Ryan, P. W., Belisle, J. T. & Inamine, J. M. (2006). A major cell wall lipopeptide of Mycobacterium avium subspecies paratuberculosis. J Biol Chem 281, 5209-5215.
12. Falkinham, J. O., III (1996). Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev 9, 177-215.
13. Fujita, Y., Okamoto, Y., Uenishi, Y., Sunagawa, M., Uchiyama, T. & Yano, I. (2007). Molecular and supra-molecular structure related differences in toxicity and granulomatogenic activity of mycobacterial cord factor in mice. Microb Pathog 43, 10-21.
14. Geisel, R. E., Sakamoto, K., Russell, D. G. & Rhoades, E. R. (2005). In vivo activity of released cell wall lipids of Mycobacterium bovis bacillus Calmette-Guérin is due principally to trehalose mycolates. J Immunol 174, 5007-5015.
15. Hayashi, D., Takii, T., Fujiwara, N., Fujita, Y., Yano, I., Yamamoto, S., Kondo, M., Yasuda, E., Inagaki, E. & other authors (2009). Comparable studies of immunostimulating activities in vitro among Mycobacterium bovis bacillus Calmette-Guérin (BCG) substrains. FEMS Immunol Med Microbiol 56, 116-128.
16. Hunter, R. L., Armitige, L., Jagannath, C. & Actor, J. K. (2009). TB research at UT-Houston-a review of cord factor: new approaches to drugs, vaccines and the pathogenesis of tuberculosis. Tuberculosis (Edinb) 89 (Suppl. 1), S18-S25.
17. Indrigo, J., Hunter, R. L., Jr & Actor, J. K. (2002). Influence of trehalose 6,69-dimycolate (TDM) during mycobacterial infection of bone marrow macrophages. Microbiology 148, 1991-1998.
18. Indrigo, J., Hunter, R. L., Jr & Actor, J. K. (2003). Cord factor trehalose 6,69-dimycolate (TDM) mediates trafficking events during mycobacterial infection of murine macrophages. Microbiology 149, 2049-2059.
19. Ishikawa, E., Ishikawa, T., Morita, Y. S., Toyonaga, K., Yamada, H., Takeuchi, O., Kinoshita, T., Akira, S., Yoshikai, Y. & Yamasaki, S. (2009). Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle. J Exp Med 206, 2879-2888.
20. Karakousis, P. C., Bishai, W. R. & Dorman, S. E. (2004). Mycobacterium tuberculosis cell envelope lipids and the host immune response. Cell Microbiol 6, 105-116.
21. Khader, S. A., Bell, G. K., Pearl, J. E., Fountain, J. J., Rangel-Moreno, J., Cilley, G. E., Shen, F., Eaton, S. M., Gaffen, S. L. & other authors (2007). IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 8, 369-377.
22. Kim, M.-J., Wainwright, H. C., Locketz, M., Bekker, L.-G., Walther, G.-B., Dittrich, C., Visser, A., Wang, W., Hsu, F.-F. & other authors (2010). Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism. EMBO Mol Med 2, 258-274.
23. Korbel, D. S., Schneider, B. E. & Schaible, U. E. (2008). Innate immunity in tuberculosis: myths and truth. Microbes Infect 10, 995-1004.
24. Korf, J., Stoltz, A., Verschoor, J., De Baetselier, P. & Grooten, J. (2005). The Mycobacterium tuberculosis cell wall component mycolic acid elicits pathogen-associated host innate immune responses. Eur J Immunol 35, 890-900.
25. Lima, V. M. F., Bonato, V. L. D., Lima, K. M., Dos Santos, S. A., Dos Santos, R. R., Gonç alves, E. D. C., Faccioli, L. H., Brandão, I. T., Rodrigues-Junior, J. M. & Silva, C. L. (2001). Role of trehalose dimycolate in recruitment of cells and modulation of production of cytokines and NO in tuberculosis. Infect Immun 69, 5305-5312.
26. Lima, K. M., Santos, S. A., Lima, V. M. F., Coelho-Castelo, A. A., Rodrigues, J. M., Jr & Silva, C. L. (2003). Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDMloaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis. Gene Ther 10, 678-685.
27. Luquin, M., Roussel, J., López-Calahorra, F., Lanéelle, G., Ausina, V. & Lanéelle, M. A. (1990). A novel mycolic acid in a Mycobacterium sp. from the environment. Eur J Biochem 192, 753-759.
28. Luquin, M., Ausina, V., Vincent-Lévy-Frebault, V., Lanéelle, M. A., Belda, F., García-Barceló, M., Prats, G. & Daffé, M. (1993). Mycobacterium brumae sp. nov., a rapidly growing, nonphotochromogenic mycobacterium. Int J Syst Bacteriol 43, 405-413.
29. Mederos, L. M., Montoro, E. H., Bernabéu, A., Linares, C. & Valero-Guillén, P. L. (2010). Structural studies of cord factors from Mycobacterium simiae related to the capacity for tumour necrosis factor alpha (a-TNF) induction. Microbiology 156, 3744-3753.
30. Méndez-Samperio, P. (2010). Role of interleukin-12 family cytokines in the cellular response tomycobacterial disease. Int J Infect Dis 14, e366-e371.
31. Minnikin, D. E. (1982). Lipids: complex lipids. In The Biology of the Mycobacteria, vol. 1, pp. 95-184. Edited by C. Ratledge & J. L. Stanford. London: Academic Press.
32. Montamat-Sicotte, D. J., Millington, K. A., Willcox, C. R., Hingley-Wilson, S., Hackforth, S., Innes, J., Kon, O.-M., Lammas, D. A., Minnikin, D. E. & other authors (2011). A mycolic acid-specific CD1-restricted T cell population contributes to acute and memory immune responses in human tuberculosis infection. J Clin Invest 121, 2493-2503.
33. Noll, H., Bloch, H., Asselineau, J. & Lederer, E. (1956). The chemical structure of the cord factor of Mycobacterium tuberculosis. Biochim Biophys Acta 20, 299-309.
34. Peyron, P., Vaubourgeix, J., Poquet, Y., Levillain, F., Botanch, C., Bardou, F., Daffé, M., Emile, J.-F., Marchou, B. & other authors (2008). Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog 4, e1000204.
35. Rao, V., Fujiwara, N., Porcelli, S. A. & Glickman, M. S. (2005). Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule. J Exp Med 201, 535-543.
36. Rao, V., Gao, F., Chen, B., Jacobs, W. R., Jr & Glickman, M. S. (2006). Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis-induced inflammation and virulence. J Clin Invest 116, 1660-1667.
37. Rhoades, E., Hsu, F. F., Torrelles, J. B., Turk, J., Chatterjee, D. & Russell, D. G. (2003). Identification and macrophage-activating activity of glycolipids released from intracellular Mycobacterium bovis BCG. Mol Microbiol 48, 875-888.
38. Russell, D. G. (2007). Who puts the tubercle in tuberculosis? Nat Rev Microbiol 5, 39-47.
39. Schoenen, H., Bodendorfer, B., Hitchens, K., Manzanero, S., Werninghaus, K., Nimmerjahn, F., Agger, E. M., Stenger, S., Andersen, P. & other authors (2010). Cutting edge: Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate. J Immunol 184, 2756-2760.
40. Takayama, K., Wang, C. & Besra, G. S. (2005). Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. Clin Microbiol Rev 18, 81-101.
41. Vander Beken, S., Al Dulayymi, J. R., Naessens, T., Koza, G., Maza-Iglesias, M., Rowles, R., Theunissen, C., De Medts, J., Lanckacker, E. & other authors (2011). Molecular structure of the Mycobacterium tuberculosis virulence factor, mycolic acid, determines the elicited inflammatory pattern. Eur J Immunol 41, 450-460.
42. Watanabe, M., Aoyagi, Y., Ridell, M. & Minnikin, D. E. (2001). Separation and characterization of individual mycolic acids in representative mycobacteria. Microbiology 147, 1825-1837.
43. Welsh, K. J., Abbott, A. N., Hwang, S.-A., Indrigo, J., Armitige, L. Y., Blackburn, M. R., Hunter, R. L., Jr & Actor, J. K. (2008). A role for tumour necrosis factor-a, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,69-dimycolate induced granulomatous response. Microbiology 154, 1813-1824.
44. Werninghaus, K., Babiak, A., Gross, O., Holscher, C., Dietrich, H., Agger, E. M., Mages, J., Mocsai, A., Schoenen, H. & other authors (2009). Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRc-Syk-Card9-dependent innate immune activation. J Exp Med 206, 89-97.
45. Zähringer, U., Lindner, B., Inamura, S., Heine, H. & Alexander, C. (2008). TLR2-promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunobiology 213, 205-224.